Followers | 132 |
Posts | 14996 |
Boards Moderated | 0 |
Alias Born | 06/04/2018 |

Monday, June 29, 2020 4:00:25 PM
Shares of Pacira BioSciences (NASDAQ: PCRX) are soaring on Monday and are up by 17.5% as of 12:10 p.m. EDT, and this despite the company not reporting any news. We can attribute Pacira's good fortune to one of its potential competitors in the market for postoperative pain, Heron Therapeutic...
Got this from PCRX - Why Pacira BioSciences Is Soaring Today
Volume: | 502,702 |
Day Range: | 25.685 - 26.28 |
Bid: | 24.00 |
Ask: | 27.10 |
Last Trade Time: | 4:05:06 PM EST |
Total Trades: | 8,978 |
Recent PCRX News
- Pacira to Report 2024 Financial Results on Thursday February 27, 2025 • GlobeNewswire Inc. • 02/20/2025 01:00:00 PM
- Investors in Pacira BioSciences, Inc. Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX • PR Newswire (US) • 02/20/2025 10:45:00 AM
- The Gross Law Firm Reminds Pacira BioSciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX • PR Newswire (US) • 02/13/2025 10:45:00 AM
- Pacira BioSciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX • PR Newswire (US) • 02/10/2025 10:45:00 AM
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/06/2025 01:00:00 PM
- The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 02/06/2025 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2025 11:26:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2025 11:25:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2025 11:25:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2025 11:25:23 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders • PR Newswire (US) • 02/03/2025 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 01:01:38 PM
- Pacira Announces Updates to Board of Directors • GlobeNewswire Inc. • 01/30/2025 01:00:00 PM
- The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 01/30/2025 10:45:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2025 10:09:22 PM
- Investors in Pacira BioSciences, Inc. Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX • PR Newswire (US) • 01/27/2025 10:45:00 AM
- Investors who lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class Action - PCRX • PR Newswire (US) • 01/23/2025 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 01:05:03 PM
- Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments • GlobeNewswire Inc. • 01/21/2025 01:00:00 PM
- Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - PCRX • PR Newswire (US) • 01/20/2025 10:45:00 AM
- Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX • PR Newswire (US) • 01/16/2025 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 01:01:45 PM
- Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization • GlobeNewswire Inc. • 01/10/2025 01:00:00 PM
- Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block • GlobeNewswire Inc. • 01/07/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 11:23:19 PM
Consumer Automotive Finance Inc. (CAFI) Completes Final Steps with FINRA, Expects Name and Ticker Change to Fifty 1 Labs, Inc. (FITY) Within 30 Days • CAFI • Feb 20, 2025 9:00 AM
UAV Corp Unveils AIG's Arrival and Cutting-Edge 3D Printing Technology, Paving the Way for Full-Scale T-Wing UAS Production and the Future of Aerospace and Defense Manufacturing • UMAV • Feb 20, 2025 8:30 AM
North Bay Resources Announces Production of 8.5 Ounces Per Ton Gold Concentrate, Bishop Gold Mill, California • NBRI • Feb 19, 2025 8:59 AM
YCRM ReachOut Technology Returns to Trading: CEO Rick Jordan Lays Out Blockchain CyberSecurity Strategy and Industry-First AI MSP Partnership In Shareholder Letter • YCRM • Feb 18, 2025 11:20 AM
VAYK Confirms No Dilution Following Recent Acquisition and 11 Million Insider Purchase • VAYK • Feb 18, 2025 9:30 AM
UAV Corp. (OTC: UMAV) Announces Nationwide Teleconference to Provide Shareholders with Key Updates on Contracts, Future Plans, and Share Structure • UMAV • Feb 18, 2025 8:30 AM